2m 2m 2m 2m 2m 2m 2m
Exelixis (EXEL)
NASDAQ
$53.28+$0.25 (+0.46%)
Price as of Aug 03, 2026 4:53 AM EDT- $13.3BMarket Cap
- 42.32%1-Year Change
- BiotechnologyIndustry
Exelixis (EXEL)
$53.28+$0.25 (+0.46%)
EXEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $53.03 | ||
Change | -$2.94 (-5.25%) | ||
Open | $55.76 | ||
High | $56.18 | ||
Low | $52.79 | ||
Previous Close | $55.97 | ||
Volume | 3,025,407 | ||
30-Day Average Volume | 2,316,255 | ||
1-Week Change | -4.23% | ||
1-Month Change | -2.54% | ||
1-Year Change | 42.32% | ||
3-Year Change | 169.05% | ||
5-Year Change | 214.72% | ||
Fundamentals | |||
Shares Outstanding | 251.4M | ||
Total Assets | $2.6B | ||
Market Cap | $13.3B | ||
Enterprise Value | $13.1B | ||
Period: QTR TTM FY | |||
Revenue | $555.0M | ||
Net Income | $210.5M | ||
Free Cash Flow | $250.3M | ||
EBIT | $267.7M | ||
EBITDA | $274.6M | ||
Net Working Capital | $837.7M | ||
EPS | $0.79 | ||
Enterprise Value/EBITDA | 48 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 7 | ||
P/E | 67 | ||
PEG | -6 | ||
Price/Free Cash Flow | 53 | ||
Price/Operating Cash Flow | 53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue